I've been out of the loop for a bit but it seems Dr. Taleb Barghouthi's Verteporfin trials are working. Hair follicle neogenesis has occurred based on biopsy results. We want to conduct a scarring alopecia trial to test if it will work in these cases as well. We want to microneedle scarred skin with Verteporfin, do incision wounds on already scarred skin and do testing of microneedling with Verteporfin on areas affected by androgenic alopecia. So far the hair regrowth has occurred on incision wounds from FUE hair transplant donor regions. Next month they will be testing Verteporfin on FUT surgeries in the donor region to regenerate it hopefully. The cost to fund a scarring alopecia study is $15,000. It would be great if we and others could help pool the money in order to fund the research. This has already been shown to work in specific cases of wounding so I think it pays to pursue. Verteporfin is a YAP (Yes Associated Protein Inhibitor). VS-6062 I am hoping we can trial as well, which is a FAK (Focal Adhesion Kinase Inhibitor). It has shown efficacy in pigs, which is very promising (unlike mice). Some believe the FAK inhibitor is even more effective. Your thoughts.......